期刊文献+

rAAV-PR39-ADM防治大鼠脑缺血/再灌注损伤的研究 被引量:6

Research on prevention and treatment effect of rAAV-PR39-ADM in cerebral ischemia reperfusion injury in rats
下载PDF
导出
摘要 目的探讨重组腺相关病毒协同表达双基因:抗菌肽(PR39)和肾上腺髓质素(adrenomedullin,ADM),即r AAVPR39-ADM对大鼠脑缺血/再灌注(ischemia/reperfusion,I/R)损伤的治疗作用。方法离体实验:人脐静脉内皮细胞培养,行血管成型实验。在体实验:建立大鼠脑I/R模型(脑缺血2 h后再灌注)。SD大鼠随机分为:Sham组、生理盐水组(I/R+NS)、空病毒组(I/R+AAV)及治疗组(I/R+r AAV-PR39-ADM组)。I/R组,再灌注24 h后股静脉分别给予等量生理盐水、空病毒及r AAV-PR39-ADM。术后1、2、3、4周,行头颅MRI、神经功能缺损评分、TTC染色及HE染色等方法评价r AAV-PR39-ADM对脑I/R损伤的疗效。结果离体实验中,r AAV-PR39-ADM同对照及空病毒组相比,有明显的促血管成型作用。在体实验中,头颅MRI检查证实模型制备成功。与Sham组相比,各时间点I/R组的神经功能缺损评分及脑组织梗塞的体积均明显增高(P<0.01),I/R组术后即刻神经功能缺损评分差异无统计学意义(P>0.05)。与生理盐水组及空病毒组相比,治疗组各时间点神经功能缺损评分及梗塞体积均明显减小(P<0.01),空病毒组与生理盐水组比较,梗塞面积及神经功能缺损评分差异无统计学意义(P>0.05)。HE染色显示,治疗组的神经元细胞数目与生理盐水组和空病毒组相比明显丰富,缺血区新生血管明显增多。结论 r AAV-PR39-ADM可能通过促进血管新生,改善脑I/R后局部供血及侧枝循环,保护神经元,促进血管再生,减轻I/R脑损伤。 Aim To investigate the curative effect of rAAV-PR39-ADM,which co-expressed the gene of an-tibacterial peptide (PR39 ) and adrenomedullin (ADM),in a rat cerebral ischemia/reperfusion (I/R) injury.Methods In vitro,Matrigel angiogenesis as-say was made with human umbilical vein endothelial cells.In vivo,the cerebral I/R model was established&nbsp;by the occlusion of the cerebral artery for 2h and then reperfused for 24 h.SD rats were randomly divided in-to sham group,I/R+normal saline group,I/R+null virus (AAV ) group, and IR +rAAV-PR39-ADM group.rAAV-PR39-ADM,saline and null virus were administered through the femoral vein after 24 h of the reperfusion in I/R group.MRI,neurological deficit&nbsp;score,TTC and HE staining were measured respective-ly 1 ,2,3 and 4 weeks after the injection in order to e-valuate the therapeutic efficacy.Results In vitro, rAAV-PR39-ADM group had significant angiogenic effect compared with sham group and null virus group. In vivo,successful I/R model was verified by the ima-ges of MRI.Compared with sham group,the nerve function defect score and the cerebral infarction size in each time nodes were significantly raised in I/R groups (P〈0.01).There was no significant difference in in-farct size and nerve function defect score between I/R+normal saline group and I/R +null virus (AAV )&nbsp;group,and obviously,the IR +rAAV-PR39-ADM group lowered these indexes compared with the other two groups.HE staining showed that the number of neurons,new capillaries vessels of I/R +PR39-ADM group were significantly more than those in group I/R and group I/R +null virus.Conclusion The treat-ment of rAAV-PR39-ADM promotes vascular forma-tion,neuron protection and reduces the infarct size in the model of cerebral ischemia/reperfusion.
出处 《中国药理学通报》 CAS CSCD 北大核心 2015年第5期641-647,共7页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81170185)
关键词 脑缺血/再灌注 PR39 肾上腺髓质素 重组腺相关病毒 基因治疗 血管生成 cerebral ischemia/reperfusion PR39 adrenomedullin recombinant adeno-associated virus gene therapy vascular formation
  • 相关文献

参考文献37

  • 1Feigin V L, Forouzanfar M H, Krishnamurthi R, et al. Global and regional burden of stroke during 1990 - 2010 : findings from the Global Burden of Disease Study 2010 [ J]. Lancet, 2014,383 (9913) : 245 -54.
  • 2Rousselet E, Kriz J, Seidah N G. Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining[J]. J Vis Exp, 2012, (69). pii:4038.
  • 3Corbyn Z. Statistics: a growing global burden [ J ]. Nature, 2014, 510(7506) : $2 -3.
  • 4Treadwell S D, Thanvi B. Malignant middle cerebral artery (MCA) infarction : pathophysiology, diagnosis and management [J]. Postgrad Med J, 2010,86(1014):235-42.
  • 5Siller-Matula J M. Hemorrhagic complications associated with aspi- rin: an underestimated hazard in clinical practice [ J ] ? Jama, 2012,307(21 ) : 2318 -20.
  • 6Derdeyn C P, Fiorella D, Lynn M J, et al. Intracranial stenting: SAMMPRISIJ]. Stroke, 2013,44(6 Suppl 1) : $41 -4.
  • 7Nikitenko L L, Smith D M, Hague S, et al. Adrenomedullin and the microvasculature [ J ]. Trends Pharrnacol Sci, 2002,23 ( 3 ) : 101 -3.
  • 8Korthuis R J, Gute D C, Blecha F, et al. PR-39, a proline/argi- nine-rich antimicrobial peptide, prevents postischemic microvascu- lar dysfunction[J]. Am J Physiol, 1999,277(3 Pt 2) : H1007 - 13.
  • 9Gennaro R, Zanetti M, Benincasa M, et al. Pro-rich antimicrobial peptides from animals: structure, biological functions and mecha- nism of action[J]. Curr Pharm Des, 2002,8(9) : 763 -78.
  • 10Hoffmeyer M R, Scalia R, Ross C R, et al. PR-39, a potent neu- trophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice [ J 1. Am J Physiol Heart Circ Physiol, 2000,279 ( 6 ) : H2824 - 8.

二级参考文献23

  • 1田士强,王任直,李桂林,王欣,张波,姚勇,窦万臣,孔燕国.大鼠局灶性脑缺血模型的改进[J].基础医学与临床,2004,24(4):449-451. 被引量:18
  • 2魏俊吉,曾立芬,樊晓彤,王裕,马文斌,李桂林,窦万臣,张振兴,栗世方,冯铭,韩钦,李照建,张子衡,康军,孔燕国,王任直,赵春华.骨髓间充质干细胞治疗大鼠缺血性脑卒中的实验研究[J].中华医学杂志,2007,87(3):184-189. 被引量:12
  • 3Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with aheplase 3 to 4.5 hours after acute ischemic stroke [ J ]. N Engl J Med,2008,359 (13) : 1317-1329.
  • 4Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral-artery occlusion without craniectomy in rats [ J]. Stroke, 1989,20( 1 ) :84-91.
  • 5Zacharek A, Shehadah A, Chen J, et al. Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment [ J ]. Stroke, 2010, 41 ( 3 ) : 524-530.
  • 6Hou S, Wang Y, Xu M, et al. Functional integration of newly generated neurons into striatum after cerebral ische- mia in the adult rat brain [ J ]. Stroke, 2008,39 ( 10 ) : 2837 -2844.
  • 7Kim SS, Yoo SW, Park TS, et al. Neural induction with neurogenin 1 increases the therapeutic effects of mesen- chymal stem cells in the ischemic brain [ J ]. Stem Cells, 2008,26(9) :2217-2228.
  • 8Leker RR, Toth ZE, Shahar T, et al. Transforming growth factor α induces angiogenesis and neurogenesis following stroke [ J ]. Neuroscience, 2009, 163 ( 1 ) : 233 -243.
  • 9Zhang Z, Wang R, Wang R, et al. Transplantation of neural stem cells modified by human neurotrophin-3 promotes functional recovery after transient focal cerebral ischemia in rats [ J ]. Neurosci Lett, 2008, 444 ( 3 ) : 227 -230.
  • 10Shen LH, Li Y, Chen J, et al. One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke [ J ]. Stroke, 2007,38 (7) :2150-2156.

共引文献13

同被引文献31

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部